Clinical trial

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

NCT01684787

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Peginterferon alfa-2a + ribavirin in normal ALT Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Peginterferon alfa-2a + ribavirin in elevated ALT Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-09-01

PhasePHASE4

Conditions

Chronic Hepatitis Cverified · MONDO: chronic hepatitis C virus infection

Interventions

Peginterferon alfa-2a + ribavirin in normal ALTDRUG

Peginterferon alfa-2a + ribavirin in elevated ALTDRUG

Sponsors & collaborators

Miguel Santinlead sponsor

Mapped research locations

MadridMadrid, Spain4 BarcelonaBarcelona, Spain3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01684787 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.